Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate vs Raloxifene in Postmenopausal Osteoporosis
NCT00790101Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by Sanofi. Started Jun 2004; status: terminated.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00790101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790101.